Capula Management’s ResMed RMD Stock Holding History

Capula Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$297K	Buy	1,523 +220	+17%	+$45.6K	﹤0.01%	480
2026 Q1	$292K	Buy	1,303 +175	+16%	+$43.6K	﹤0.01%	654
2025 Q4	$272K	Buy	1,128 +493	+78%	+$126K	﹤0.01%	518
2025 Q3	$174K	Buy	+635	New	+$173K	﹤0.01%	640
2024 Q1	–	Sell	-2,465	Closed	-$424K	–	582
2023 Q4	$424K	Buy	+2,465	New	+$379K	0.02%	170
2023 Q3	–	Sell	-2,260	Closed	-$494K	–	644
2023 Q2	$494K	Buy	+2,260	New	+$504K	0.01%	294
2023 Q1	–	Sell	-2,070	Closed	-$431K	–	897
2022 Q4	$431K	Buy	+2,070	New	+$455K	0.01%	614
2021 Q4	–	Sell	-1,658	Closed	-$437K	–	663
2021 Q3	$437K	Buy	+1,658	New	+$453K	0.01%	624

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capula Management's RMD Position: Q2 2026 in Review

Capula Management increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $45.6K and bringing the position to 1,523 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Capula Management first reported a position in RMD in Q3 2021 and has held it in 8 quarters since. The position peaked at $494K in Q2 2023. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Capula Management held 1,523 shares of ResMed worth $297K as of Q2 2026.
Capula Management bought 220 ResMed shares in Q2 2026, an estimated $45.6K.
ResMed made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #480 holding.
Capula Management first reported a position in ResMed in Q3 2021 and has held it in 8 quarters since.
Capula Management's ResMed position peaked at $494K in Q2 2023.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.